BRIEF — Otofarma Sees In 2028 EBITDA Between €2.8 — 3.2 Mln

Oct 13 (Reuters) — Otofarma SpA: Board Of Directors Approves Strategic Guidelines Of 2026-2028 Business Plan Sees In 2028 Revenues Between €28.5-31.0 Mln Sees In 2028 Ebitda Between €2.8-3.2 Mln Sees In 2028 Ebitda Margin Between 9.8% And 10.3% Sees Investments For Overall €6.3 Mln Over Plan Horizon Sees Net Cash At End Of 2028 Between €1.2-1.4 Mln Further company coverage: OTO.MI (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;)